Being offered a new hormone tablet can raise understandable concerns — especially about fatigue, thinking clearly, balance, and day-to-day functioning.
Darolutamide is a modern treatment designed to control prostate cancer while minimising effects on the brain for many people.
In simple terms
Darolutamide blocks testosterone signals inside prostate cancer cells.
It is used alongside standard hormone therapy and is designed to be effective with fewer effects on thinking and balance.
PBS-approved indications in Australia
Darolutamide is PBS-listed for use in specific prostate cancer settings, including:
• Metastatic castration-sensitive prostate cancer
• Non-metastatic castration-resistant prostate cancer
What these terms mean
Metastatic castration-sensitive prostate cancer
This means the cancer has spread to other parts of the body (such as bone or lymph nodes) but is still responding to hormone therapy that lowers testosterone.
In this setting, darolutamide is added to standard hormone therapy to improve cancer control and outcomes.
Non-metastatic castration-resistant prostate cancer
This means testosterone is already kept very low with hormone therapy, but the cancer has started to grow again without visible spread on scans.
Even though scans do not yet show metastases, treatment is important because the cancer has shown it can progress. Darolutamide helps delay spread and maintain control.
Who this treatment may suit
Darolutamide may be particularly suitable for people who:
• are concerned about cognitive side effects or “brain fog”
• want to reduce the risk of balance problems or falls
• wish to maintain independence, work, and daily routines
What darolutamide does
Darolutamide is an androgen receptor inhibitor. It blocks testosterone signalling inside cancer cells and is always used together with ongoing hormone therapy, not instead of it.
Why it is often better tolerated
A key feature of darolutamide is its low penetration into the brain compared with some other hormone tablets in the same class.
In practice, this often translates into:
• fewer effects on concentration and thinking
• fewer balance-related issues
• better preservation of day-to-day function
Individual experiences vary, but this property is an important reason darolutamide is often chosen.
What side effects can still occur
Darolutamide can still cause fatigue and other hormone-related effects, and it can interact with some medications. Side effects are usually manageable with monitoring and follow-up.
A practical reassurance
If clarity of thinking, balance, and steady energy matter to your work or lifestyle, it is reasonable to ask your oncologist whether darolutamide is an appropriate option for you.
Why this matters
Treatment is not only about controlling cancer.
It is also about preserving confidence, independence, and quality of life over time.
Key takeaway
Darolutamide is a PBS-approved treatment for selected stages of prostate cancer.
It provides strong cancer control while aiming to reduce effects on the brain.
For many patients, it offers treatment that works without taking away how they live.